Thousands of people in Britain are suffering from a mysterious and debilitating dermatological condition that has stumped doctors. Sufferers report their skin becoming intensely inflamed with cracking and peeling, commonly affecting large areas of their body, yet many doctors struggle to diagnose or treat the condition. The condition, called topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on online platforms, with videos documenting patients’ experiences accumulating over one billion views on TikTok alone. Even though it impacts a rising number of people, TSW remains so inadequately understood that some general practitioners and dermatologists doubt whether it exists at all. Now, in a first-of-its-kind move, researchers across the UK are launching a large-scale study to examine what is responsible for these unexplained symptoms and how some people come to develop the condition whilst others do not.
The Unexplained Illness Spreading Across the UK
Bethany Gamble’s case exemplifies the devastating impact of topical steroid withdrawal on sufferers’ lives. The 21-year-old from Birmingham had handled her eczema successfully with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became acutely inflamed with redness, breaking and leaking whilst the itching became what she refers to as “bone deep”. Within two years, the pain had become so severe that she was unable to leave her bed, requiring round-the-clock care from her mother. Most concerning, Bethany found herself repeatedly dismissed by healthcare providers who blamed her symptoms on standard eczema and persistently prescribed the very treatments she thought were responsible for her suffering.
The healthcare sector remains divided on how to approach TSW, with significant discord about its very nature. Some experts view it as a debilitating allergic reaction to the steroid creams that represent the standard treatment for eczema across the NHS. Others maintain it represents a serious exacerbation of pre-existing skin conditions rather than a unique syndrome, whilst a minority doubt of its existence altogether. This lack of professional consensus has left patients like Bethany caught in a state of diagnostic limbo, struggling to access suitable treatment. The lack of consensus has encouraged Professor Sara Brown at the University of Edinburgh to create the inaugural major UK research project studying TSW, funded by the National Eczema Society.
- Symptoms comprise significant swelling, cracking skin and intense itching across the body
- Patients report “elephant skin” thickening and extreme shedding of keratinised cells
- Healthcare practitioners commonly disregard TSW as typical dermatitis or refuse to acknowledge it
- The condition can be so incapacitating that sufferers become unable to perform daily activities
Living with Topical Steroid Withdrawal
From Controllable Eczema to Disabling Symptoms
For many patients, withdrawal from topical steroids represents a severe decline from a previously stable skin condition. What starts with intermittent itching in skin creases can rapidly escalate into a full-body inflammatory response that leaves patients unable to function. The transition often occurs suddenly, unexpectedly, converting a controllable long-term condition into an severe medical emergency. Patients report their skin turning intensely hot, red and inflamed, with severe cracking and oozing that requires ongoing care. The bodily burden is compounded by exhaustion, as the persistent itching prevents sleep and recovery, establishing a destructive cycle of deterioration.
The pace at which TSW develops takes many sufferers by surprise. Those who have experienced eczema for years, sometimes decades, are unprepared for the severity of symptoms that appear when their condition rapidly deteriorates. Everyday tasks become monumental challenges: showering becomes excruciating, dressing requires assistance, and keeping clean demands enormous effort. Some patients describe feeling as though their skin is being attacked from within, with inflammation spreading across their body in patterns that bear little resemblance to their previous eczema flare-ups. This marked shift often drives sufferers to seek urgent medical help, only to meet with doubt from healthcare professionals.
The Battle for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the dismissive medical responses that frequently accompanies it. Patients presenting with severe, unexplained symptoms are routinely told they merely suffer from eczema flaring up, despite their insistence that this is essentially distinct from anything they’ve experienced before. Doctors frequently react by prescribing stronger steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This cycle of dismissal leaves sufferers feeling abandoned by the healthcare system, compelled to manage their illness alone whilst being informed that their personal experience lacks validity. Many patients report feeling gaslit repeatedly, their concerns dismissed as emotional or psychological in nature rather than genuine physiological symptoms.
The lack of medical consensus has created a significant divide between what patients report and professional recognition. Without established diagnostic standards or established treatment protocols, GPs and dermatologists find it difficult to diagnose TSW or provide suitable care. Some practitioners remain entirely unconvinced the condition exists, viewing all severe presentations as standard eczema or other known dermatological conditions. This professional uncertainty translates into diagnostic delays, unsuitable therapies and significant emotional suffering for people experiencing physical symptoms. The increased prominence of TSW on social media has highlighted this diagnostic void, prompting researchers to investigate what thousands of people claim to be experiencing, even as the healthcare profession remains divided on the appropriate response.
- Signs may develop suddenly in individuals with previously stable eczema managed by steroid creams
- Patients often face disbelief from medical practitioners who ascribe worsening to standard eczema flares
- Healthcare providers continue to disagree on whether TSW is a genuine condition or severe eczema exacerbation
- Absence of established diagnostic standards means many sufferers struggle to access suitable care and support
- Social media has amplified patient voices, with TSW hashtags reaching over a billion views worldwide
Ethnic Inequalities in Assessment and Clinical Management
The diagnostic challenges surrounding TSW become more acute amongst those with darker complexions, where symptoms can be considerably more difficult to recognise visually. Redness and inflammation, the characteristic indicators of TSW in people with lighter skin, present distinctly across multiple populations, yet many assessment protocols remain centred on how the condition appears in white patients. This difference means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW commonly experience significantly extended timeframes in recognition and validation. Healthcare professionals trained primarily on presentations in lighter skin may overlook or misinterpret the defining features, causing continued misidentification and incorrect management approaches that can worsen symptoms.
Research into TSW has traditionally overlooked the experiences of people with darker complexions, sustaining a pattern where their condition goes insufficiently documented and inadequately researched. The social media conversations dominating TSW discussions have been predominantly influenced by voices with lighter skin, potentially skewing medical understanding and community understanding. As Professor Sara Brown’s groundbreaking UK study progresses, guaranteeing inclusive participation amongst research participants will be crucial to creating genuinely comprehensive diagnostic criteria and treatment approaches. Without intentional action to prioritise the perspectives of all ethnic groups, treatment inequalities in TSW identification and care risk widening further, leaving vulnerable populations without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Treatment and Research Solutions Emerging
Leading UK Study Underway
Professor Sara Brown’s landmark research at the University of Edinburgh marks a turning point for TSW sufferers pursuing validation and understanding. With backing from the National Eczema Society, the study has enrolled hundreds of participants across the UK to examine the physiological processes behind topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers aim to identify why certain individuals experience TSW whilst others using identical steroid regimens do not. This rigorous investigation marks a important transition from dismissal to thorough inquiry.
The research team working alongside Dr Alice Burleigh from advocacy group for patients Scratch That, brings both medical knowledge and personal experience to the study. Their partnership approach acknowledges that patients themselves hold crucial insights into their health situations. Professor Brown has noted patterns in TSW that defy explanation by conventional eczema understanding, including marked “elephant skin” thickening, severe shedding and clearly defined areas of inflammation. The study’s findings could substantially alter how doctors approach diagnosis and management of this disabling illness.
Treatment Options and Their Limitations
At present, therapeutic approaches to TSW remain limited and often unsatisfactory. Many clinicians persist in prescribing topical steroids notwithstanding evidence indicating they could worsen symptoms in susceptible individuals. Some patients describe short-term improvement from emollients, antihistamines and oral medications, though outcomes differ significantly. Dermatologists remain divided on best treatment approaches, with some recommending full steroid withdrawal whilst others recommend gradual tapering. This lack of consensus sees patients managing their therapeutic pathways largely alone, depending significantly on peer support networks and online communities for direction.
Psychological support and specialist dermatological care offer potential benefits, yet access remains patchy across the NHS. Some patients have investigated complementary methods including changes to diet, environmental controls and whole-person treatment approaches, though scientific evidence validating such approaches is limited. The lack of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than research-informed standards. Until robust research yields conclusive findings, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollient creams and hydrating products to enhance the skin’s protective barrier and reduce water loss
- Antihistamine medications to control itching and related sleep disruption during flare-ups
- Systemic corticosteroids or immunosuppressants for severe cases under specialist supervision
- Psychological counselling to address emotional distress and worry stemming from chronic skin conditions
Voices of Hope and Determination
Despite the lack of clarity regarding TSW and the often dismissive perspectives from medical practitioners, patients are gaining resilience in shared community and collective experience. Digital support communities have proven vital for those struggling with the disorder, providing practical guidance and validation when conventional medicine has failed them. Many individuals affected recount the point at which they found the TSW hashtag as pivotal—finally finding others with the same symptoms and realising they were not isolated in their suffering. This collective voice has been powerful enough to prompt the first serious research efforts, demonstrating that patient-led campaigns can advance medical understanding even when established institutions remain sceptical.
Bethany Gamble and people in similar situations are determined to increase visibility and advocate for appropriate acknowledgement of TSW within the medical establishment. Their readiness to share deeply personal accounts of their struggles on social media has made discussions more commonplace around a condition that numerous physicians still refuse to acknowledge. These patients are not remaining passive for answers; they are engaging in scientific investigations, recording their manifestations meticulously, and insisting that their testimonies be treated with respect. Their determination in the confronting persistent distress and medical gaslighting provides encouragement that answers may finally be within grasp, and that those to come will be given the acknowledgement and treatment they so desperately need.
- Community-driven research projects are addressing shortcomings overlooked by conventional healthcare systems and advancing knowledge of TSW
- Digital support networks offer emotional support, practical coping strategies, and mutual recognition for isolated sufferers globally
- Advocacy efforts are incrementally changing clinical attitudes, prompting dermatologists to investigate rather than dismiss patient concerns
